UDOW vs. CURE

Last updated Apr 1, 2026

Compare and contrast key facts about ProShares UltraPro Dow30 (UDOW) and Direxion Daily Healthcare Bull 3x Shares (CURE).

UDOW and CURE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. UDOW is a passively managed fund by ProShares that tracks the performance of the Dow Jones Industrial Average (300%). It was launched on Feb 9, 2010. CURE is a passively managed fund by Direxion that tracks the performance of the Health Care Select Sector Index (300%). It was launched on Jun 15, 2011. Both UDOW and CURE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

UDOW vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares UltraPro Dow30 (UDOW) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

UDOW vs. CURE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
UDOW ProShares UltraPro Dow30	-13.10%	24.46%	28.47%	32.72%	-32.39%	65.67%	-17.15%	75.24%	-23.86%	99.07%
CURE Direxion Daily Healthcare Bull 3x Shares	-17.66%	22.55%	-8.47%	-9.40%	-20.51%	88.30%	5.02%	55.66%	2.82%	69.32%

Returns By Period

In the year-to-date period, UDOW achieves a -13.10% return, which is significantly higher than CURE's -17.66% return. Over the past 10 years, UDOW has outperformed CURE with an annualized return of 20.30%, while CURE has yielded a comparatively lower 13.32% annualized return.

UDOW

• 1D: 7.38%
• 1M: -16.17%
• YTD: -13.10%
• 6M: -5.67%
• 1Y: 16.04%
• 3Y*: 23.31%
• 5Y*: 10.24%
• 10Y*: 20.30%

CURE

• 1D: 5.69%
• 1M: -23.73%
• YTD: -17.66%
• 6M: 10.27%
• 1Y: -12.92%
• 3Y*: -0.17%
• 5Y*: 3.15%
• 10Y*: 13.32%

*Multi-year figures are annualized to reflect compound growth (CAGR)

UDOW vs. CURE - Expense Ratio Comparison

UDOW has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.

CURE

Direxion Daily Healthcare Bull 3x Shares

UDOW

ProShares UltraPro Dow30

Return for Risk

UDOW vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UDOW

UDOW Risk / Return Rank: 27
UDOW Sharpe Ratio Rank: 22
UDOW Sortino Ratio Rank: 29
UDOW Omega Ratio Rank: 29
UDOW Calmar Ratio Rank: 29
UDOW Martin Ratio Rank: 28

CURE

CURE Risk / Return Rank: 9
CURE Sharpe Ratio Rank: 8
CURE Sortino Ratio Rank: 10
CURE Omega Ratio Rank: 10
CURE Calmar Ratio Rank: 8
CURE Martin Ratio Rank: 8

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UDOW vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares UltraPro Dow30 (UDOW) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	UDOW	CURE	Difference
Sharpe ratio Return per unit of total volatility	0.32	-0.25	+0.57
Sortino ratio Return per unit of downside risk	0.81	0.00	+0.80
Omega ratio Gain probability vs. loss probability	1.11	1.00	+0.11
Calmar ratio Return relative to maximum drawdown	0.65	-0.28	+0.93
Martin ratio Return relative to average drawdown	2.13	-0.50	+2.63
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

UDOW vs. CURE - Sharpe Ratio Comparison

The current UDOW Sharpe Ratio is 0.32, which is higher than the CURE Sharpe Ratio of -0.25. The chart below compares the historical Sharpe Ratios of UDOW and CURE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	UDOW	CURE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.32	-0.25	+0.57
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.23	0.07	+0.16
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.39	0.27	+0.12
Sharpe Ratio (All Time) Calculated using the full available price history	0.50	0.47	+0.03

Correlation

The correlation between UDOW and CURE is 0.72, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Dividends

UDOW vs. CURE - Dividend Comparison

UDOW's dividend yield for the trailing twelve months is around 1.56%, more than CURE's 1.30% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
UDOW ProShares UltraPro Dow30	1.56%	1.38%	0.95%	0.95%	0.83%	0.26%	0.19%	0.61%	0.73%	0.13%	0.26%	0.21%
CURE Direxion Daily Healthcare Bull 3x Shares	1.30%	1.12%	1.17%	2.02%	0.38%	0.02%	0.17%	0.40%	0.70%	0.18%	0.00%	0.00%

Drawdowns

UDOW vs. CURE - Drawdown Comparison

The maximum UDOW drawdown since its inception was -80.29%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for UDOW and CURE.

Drawdown Indicators

	UDOW	CURE	Difference
Max Drawdown Largest peak-to-trough decline	-80.29%	-69.19%	-11.10%
Max Drawdown (1Y) Largest decline over 1 year	-30.18%	-33.92%	+3.74%
Max Drawdown (5Y) Largest decline over 5 years	-55.79%	-52.23%	-3.56%
Max Drawdown (10Y) Largest decline over 10 years	-80.29%	-69.19%	-11.10%
Current Drawdown Current decline from peak	-22.46%	-34.64%	+12.18%
Average Drawdown Average peak-to-trough decline	-14.46%	-17.94%	+3.48%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.21%	20.16%	-10.95%

Volatility

UDOW vs. CURE - Volatility Comparison

ProShares UltraPro Dow30 (UDOW) has a higher volatility of 14.74% compared to Direxion Daily Healthcare Bull 3x Shares (CURE) at 13.92%. This indicates that UDOW's price experiences larger fluctuations and is considered to be riskier than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UDOW	CURE	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.74%	13.92%	+0.82%
Volatility (6M) Calculated over the trailing 6-month period	27.64%	30.96%	-3.32%
Volatility (1Y) Calculated over the trailing 1-year period	50.20%	52.88%	-2.68%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.05%	43.34%	+0.71%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	51.68%	49.47%	+2.21%